 JUPITER, Fla., Oct. 27, 2021 GLOBE NEWSWIRE -- Dyadic International, Inc. Dyadic, we, us, our, or the Company NASDAQ: DYAI, a global biotechnology company focused on further improving, applying and deploying its proprietary C1-cell protein production platform to accelerate development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales, today announced that it will report its financial results for the third quarter ended September 30, 2021 and host a corporate update conference call on Wednesday, November 10, 2021. 